Tibet Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TBET research report →
Price Chart
About the company
Tibet Pharmaceuticals, Inc. operates as a specialized pharmaceutical company, primarily focused on the research, development, manufacturing, marketing, and distribution of traditional Tibetan medicines. The company conducts its core activities through its operational subsidiary, Yunnan Shangri-La Tibetan Pharmaceutical Group Limited (YSTP), which develops products within China to support the health of human respiratory, digestive, urinary, and reproductive systems.
- CEO
- Hong Yu
- IPO
- 2023
- Employees
- 190
- HQ
- Wanchai, HK
Get TickerSpark's AI analysis on TBET
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.49K
- P/E
- 0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.53
- Div Yield
- 0.00%
- Gross Margin
- 49.98%
- Op Margin
- 41.14%
- Net Margin
- 40.61%
- ROE
- 77.26%
- ROIC
- 0.00%
Latest fiscal year · YoY change
- Revenue
- $32.36M+40.7%
- Gross Profit
- $16.18M+38.2%
- Op Income
- $13.32M
- Net Income
- $13.14M+42.2%
- EPS
- $1.11+40.5%
- OCF Growth
- -24.0%
- FCF Growth
- -25.4%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -20.47
- RSI (14)
- 67
- Avg Volume
- 3.17K
No earnings-call transcripts are available for TBET yet.
- Free Float
- 47.7%
- Shares Outstanding
- 14.85M
- Float Shares
- 7.08M
Our TBET coverage
Recent articles, reports, and earnings notes.
No research on TBET yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TBET report →